---
title: "A resolution expressing support for the designation of the month of May 2018 as \"National Bladder Cancer Awareness Month\"."
identifier: "115-SRES-510"
congress: 115
bill_number: 510
bill_type: "SRES"
version_code: "ats"
version_type: "ats"
bill_url: "https://chamberzero.com/congresses/115/bills/sres/510"
source: "https://www.congress.gov/bill/115th-congress/senate-resolution/510"
site: "Chamber Zero"
site_url: "https://chamberzero.com"
rendered_at: "2026-06-04T11:49:52.371Z"
---
Whereas more than 700,000 people in the United States live with bladder cancer;Whereas more than 81,000 people are expected to be diagnosed with bladder cancer and more than 17,000 will die due to the disease in 2018 alone;Whereas bladder cancer affects people of all ages and backgrounds and is among the top 10 cancers with the highest incidence rates in the United States;Whereas bladder cancer is known as one of the most expensive cancers to treat on a per patient basis, with a recurrence rate of approximately 50 to 80 percent, requiring lifelong surveillance;Whereas bladder cancer symptoms, such as blood in the urine, are easily recognized, however, many are unaware of the threat of bladder cancer, often prolonging the time to diagnosis;Whereas, if diagnosed early, bladder cancer is treatable;Whereas military veterans are twice as likely as nonveterans to be diagnosed with bladder cancer;Whereas women are often diagnosed at a later stage in the development of bladder cancer, and when diagnosed at the same stage as men, women have a worse prognosis;Whereas, if diagnosis and treatment are delayed, the life expectancy of an individual with bladder cancer decreases;Whereas the quality of life of a person with bladder cancer will depend on future treatment and diagnosis developments, which will rely on research advancements;Whereas research advancements for bladder cancer are limited by a lack of awareness about the disease within the medical community and the general public;Whereas increased awareness of bladder cancer will promote early diagnosis and increase the chances of survival;Whereas increased awareness of bladder cancer will bolster public support of the disease and thus increase funding for innovative research and the development of new treatment options and diagnostic tools;Whereas, traditionally, on the first Saturday in May each year, survivors, caregivers, and loved ones walk together throughout the United States to raise awareness of bladder cancer;Whereas the Bladder Cancer Advocacy Network and its community of patients, caregivers, and specialists seek—(1)to foster a community of hope and support;(2)to fund and conduct research for innovative treatments and diagnostic tools; and(3)to increase public awareness and understanding of bladder cancer; andWhereas May would be an appropriate month to designate as “National Bladder Cancer Awareness Month”: Now, therefore, be itThat the Senate—
  - (1) supports the designation of May 2018 as "National Bladder Cancer Awareness Month";
  - (2) supports the goals and ideals of National Bladder Cancer Awareness Month; and
  - (3) calls on the people of the United States, interested groups, and affected persons—
    - (A) to promote awareness of bladder cancer and to foster understanding of the impact of the disease on patients and their families and caregivers;
    - (B) to take an active role in the fight to end bladder cancer; and
    - (C) to observe National Bladder Cancer Awareness Month with appropriate ceremonies and activities.